Navigation Links
Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
Date:3/6/2009

MOUNTAIN VIEW, Calif., March 6 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it will release results for its fiscal year ended December 31, 2008, on Tuesday, March 10, 2009, following the close of the U.S. financial markets. The Company will host an investor conference call to discuss the financial results and other clinical development updates at 4:30 p.m. Eastern Time the same day. A replay of the call will be available for two weeks following the event. The conference call, replay and webcast are open to all interested parties.

To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link. Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required. Interested parties may also pre-register to avoid pre-call delays at https://www.theconferencingservice.com/prereg/key.process?key=P9J9NFRUU.

To access the live conference call via phone, dial 888-713-4213. International callers may access the live call by dialing 617-213-4865. The reference number to enter the call is 63442394.

The replay of the conference call may be accessed via the Internet, at www.alexza.com, or via phone at 888-286-8010 for domestic callers or 617-801-6888 for international callers. The reference number for the replay of the call is 94291130.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. Th
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
4. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
5. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
6. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
7. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
8. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
9. Alexza to Webcast Investor and Analyst Day Presentations
10. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
11. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Park Cities Pet Sitter , Inc. has announced ... donation drive that benefits the animal shelter and rescue communities. ... with the Humane Society of the United States’ Animal Shelter ... , As part of their participation, Park Cities Pet Sitter ... the Presents 4 Pets drive from their client base, as ...
(Date:8/20/2014)... PITTSBURGH, Aug. 20, 2014 A common approach to ... blood did not improve survival chances for people who ... experts at the University of Pittsburgh School of Medicine. ... PLOS One , suggest acute hemodialysis, an aggressive method ... failure, may not provide a definitive benefit to the ...
(Date:8/20/2014)... With 3943.8% growth, Connexion Point ranks number ... fastest growing companies. The Inc. 500 ranks Connexion Point 12th, ... Point is the #1 fastest growing company in Utah. , ... and its clients include four of the top 10 health ... and has offices and contact centers in Salt Lake City, ...
(Date:8/20/2014)... cancer - using Botox. A study presented in the ... shows that cancer growth could be suppressed by eliminating ... cancer stem cells. The approach thus treated the cancer. ... and efficient. The researchers have thus far tested the ... humans. , The nervous system is crucial in regulating ...
(Date:8/20/2014)... most common cause of endophthalmitis, a potentially blinding condition ... eye injections, are the well-known staphylococci ("staph") ... a study published in the August issue of ... years of cases at New York Eye and Ear ... study found that gram-positive bacteria, which include staph and ...
Breaking Medicine News(10 mins):Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Treating gastric cancer -- with Botox 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 3
... Pills Can Make Headaches Worse, YONKERS, N.Y., ... from frequent headaches to talk to their doctors,before ... prescription,and over-the-counter pain medications can make headaches worse, ... who reports in,CR,s October issue on how some ...
... Resources and Helpline Now,Available, HARRISBURG, Pa., Sept. 2 ... Indoor Air Act fast approaching, the,Department of Health is ... the law that will ban smoking in most public ... Guidance and a downloadable toolkit for public places ...
... new presidential,administration on the way, health care reform ... on what may come, attendees of the 2008,Republican ... than,Halleland Health Consulting, which is making itself available ... group and its law firm parent -- Minneapolis-based,Halleland ...
... Inc.,(NYSE: CSA ) announces the signing of ... office building and outpatient treatment center in,Pensacola, Florida., ... first synergy project since the,closing of the merger ... Spencer Company). The project will include design/build,(architectural, engineering ...
... Californians took benefit of nation,s 1st such law, passed in ... with chronically ill kids have made use of California,s pioneering ... even aware it exists, according to researchers at the Rand ... family leave law. It is funded by employees through an ...
... Pollution, HARRISBURG, Pa., Sept. 2 The ... partnerships have,forecast an air quality action day for ... air quality forecast predicts Wednesday will be code ... Washington and,Westmoreland counties., The U.S. Environmental Protection ...
Cached Medicine News:Health News:Consumer Reports Urges Chronic Headache Sufferers to Examine Their Use of Pain Relief Drugs 2Health News:Consumer Reports Urges Chronic Headache Sufferers to Examine Their Use of Pain Relief Drugs 3Health News:PA Department of Health Reminds Businesses to Prepare to Implement Clean Indoor Air Act 2Health News:INTERVIEW AVAILABILITY: Halleland Health Consulting Makes Health Policy Expertise Available During RNC Week 2Health News:Cogdell Spencer Announces First Synergy Project in Pensacola, Florida 2Health News:Cogdell Spencer Announces First Synergy Project in Pensacola, Florida 3Health News:Paid Family Leave Program Goes Mostly Unused 2Health News:Air Quality Action Day Forecast Wednesday for Pittsburgh Region 2
(Date:8/20/2014)... Trovagene, Inc. (NASDAQ:   TROV), a developer ... two clinical studies will be presented at the 29th ... test for the detection of high risk strains of ... take place in Seattle from ... a new U.S. patent was issued earlier this year ...
(Date:8/20/2014)... , August 20, 2014 ... Conducted in the US  KalVista Pharmaceuticals ("KalVista"), ... edema (DME), today announces that it has begun a ... plasma kallikrein inhibitor, KVD001, for the treatment of DME. ... of the Beetham Eye Institute, Joslin Diabetes Center; Harvard ...
(Date:8/19/2014)... , Aug. 19, 2014 Minimally Invasive Devices ... medical device company, announced today that Mitsubishi Corporation has ... robotic visualization system in Japan . ... in Japan in the second ... the exclusive distributor for Karl Storz GMBH & Co. ...
Breaking Medicine Technology:Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2